{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:14:56Z","timestamp":1789568096167,"version":"build-2803163510"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"7","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Homing to secondary lymphoid organs and bone marrow (BM) is a central aspect of leukemic pathophysiology. We investigated the roles of the two major lymphocyte integrins LFA-1 and VLA-4 on B-cell chronic lymphocytic leukemia (CLL) cells in these processes. We found that the majority of CLL cells expressed significantly reduced LFA-1 due to low \u03b22 integrin transcripts. VLA-4 expression was heterogenous but underwent rapid activation by the BM chemokine CXCL12. CLL cells failed to transmigrate across VCAM-1\u2013expressing, ICAM-1\u2013expressing, and CXCL12-expressing endothelium, whereas when LFA-1 expression was regained in subsets of CLL cells, these lymphocytes rapidly transmigrated the endothelium. Furthermore, when injected into tail veins of immunodeficient mice, normal B cells rapidly homed to lymph nodes (LN) in a LFA-1\u2013dependent manner, whereas CLL cells did not. Nevertheless, only residual CLL subsets could reenter BM, whereas both normal and CLL cells homed to the mice spleen in an LFA-1\u2013independent and VLA-4\u2013independent manner. Our results suggest that CLL cells have a reduced capacity to adhere and transmigrate through multiple vascular endothelial beds and poorly home to lymphoid organs other than spleen. Integrin blocking could thus be an efficient strategy to prevent circulating CLL cells from reaching prosurvival niches in LNs and BM but not in spleen. [Cancer Res 2009;69(7):OF3121\u201330]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-4136","type":"journal-article","created":{"date-parts":[[2009,3,17]],"date-time":"2009-03-17T22:13:29Z","timestamp":1237328009000},"page":"3121-3130","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Circulating B-Cell Chronic Lymphocytic Leukemia Cells Display Impaired Migration to Lymph Nodes and Bone Marrow"],"prefix":"10.1158","volume":"69","author":[{"given":"Tanja Nicole","family":"Hartmann","sequence":"first","affiliation":[{"name":"1Laboratory for Immunological and Molecular Cancer Research, Third Medical Department, Salzburg University Hospital, Salzburg, Austria;"},{"name":"2Department of Immunology, Weizmann Institute of Science;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Grabovsky","sequence":"additional","affiliation":[{"name":"2Department of Immunology, Weizmann Institute of Science;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"1Laboratory for Immunological and Molecular Cancer Research, Third Medical Department, Salzburg University Hospital, Salzburg, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Desch","sequence":"additional","affiliation":[{"name":"1Laboratory for Immunological and Molecular Cancer Research, Third Medical Department, Salzburg University Hospital, Salzburg, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Rubenzer","sequence":"additional","affiliation":[{"name":"1Laboratory for Immunological and Molecular Cancer Research, Third Medical Department, Salzburg University Hospital, Salzburg, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Wollner","sequence":"additional","affiliation":[{"name":"4Department of Internal Medicine, Freiburg University Clinic, Freiburg, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Binsky","sequence":"additional","affiliation":[{"name":"2Department of Immunology, Weizmann Institute of Science;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Vallon-Eberhard","sequence":"additional","affiliation":[{"name":"2Department of Immunology, Weizmann Institute of Science;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Sapoznikov","sequence":"additional","affiliation":[{"name":"2Department of Immunology, Weizmann Institute of Science;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Burger","sequence":"additional","affiliation":[{"name":"4Department of Internal Medicine, Freiburg University Clinic, Freiburg, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idit","family":"Shachar","sequence":"additional","affiliation":[{"name":"2Department of Immunology, Weizmann Institute of Science;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Haran","sequence":"additional","affiliation":[{"name":"3Hematology Institute, Kaplan Medical Center, Rehovot, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Honczarenko","sequence":"additional","affiliation":[{"name":"5Biogen Idec, Inc., Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Greil","sequence":"additional","affiliation":[{"name":"1Laboratory for Immunological and Molecular Cancer Research, Third Medical Department, Salzburg University Hospital, Salzburg, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Alon","sequence":"additional","affiliation":[{"name":"2Department of Immunology, Weizmann Institute of Science;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2009,4,1]]},"reference":[{"key":"2022061701472331200_B1","doi-asserted-by":"crossref","unstructured":"Stauder R, Hamader S, Fasching B, Kemmler G, Thaler J, Huber H. Adhesion to high endothelial venules: a model for dissemination mechanisms in non-Hodgkin's lymphoma. Blood\u20081993; 82: 262\u20137.","DOI":"10.1182\/blood.V82.1.262.bloodjournal821262"},{"key":"2022061701472331200_B2","doi-asserted-by":"crossref","unstructured":"Caligaris-Cappio F, Riva M, Tesio L, Schena M, Gaidano G, Bergui L. Human normal CD5+ B lymphocytes can be induced to differentiate to CD5\u2212 B lymphocytes with germinal center cell features. Blood\u20081989; 73: 1259\u201363.","DOI":"10.1182\/blood.V73.5.1259.1259"},{"key":"2022061701472331200_B3","doi-asserted-by":"crossref","unstructured":"Alon R, Luscinskas FW. Crawling and INTEGRating apical cues. Nat Immunol\u20082004; 5: 351\u20133.","DOI":"10.1038\/ni0404-351"},{"key":"2022061701472331200_B4","doi-asserted-by":"crossref","unstructured":"Shimonaka M, Katagiri K, Nakayama T, et al. Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow. J Cell Biol\u20082003; 161: 417\u201327.","DOI":"10.1083\/jcb.200301133"},{"key":"2022061701472331200_B5","doi-asserted-by":"crossref","unstructured":"Alon R, Feigelson S. From rolling to arrest on blood vessels: leukocyte tap dancing on endothelial integrin ligands and chemokines at sub-second contacts. Semin Immunol\u20082002; 14: 93\u2013104.","DOI":"10.1006\/smim.2001.0346"},{"key":"2022061701472331200_B6","doi-asserted-by":"crossref","unstructured":"Kinashi T. Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol\u20082005; 5: 546\u201359.","DOI":"10.1038\/nri1646"},{"key":"2022061701472331200_B7","doi-asserted-by":"crossref","unstructured":"Peled A, Kollet O, Ponomaryov T, et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial\/stromal migration and engraftment of NOD\/SCID mice. Blood\u20082000; 95: 3289\u201396.","DOI":"10.1182\/blood.V95.11.3289.011k33_3289_3296"},{"key":"2022061701472331200_B8","doi-asserted-by":"crossref","unstructured":"Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD\/SCID mice on CXCR4. Science\u20081999; 283: 845\u20138.","DOI":"10.1126\/science.283.5403.845"},{"key":"2022061701472331200_B9","doi-asserted-by":"crossref","unstructured":"Imai K, Kobayashi M, Wang J, et al. Selective secretion of chemoattractants for haemopoietic progenitor cells by bone marrow endothelial cells: a possible role in homing of haemopoietic progenitor cells to bone marrow. Br J Haematol\u20081999; 106: 905\u201311.","DOI":"10.1046\/j.1365-2141.1999.01644.x"},{"key":"2022061701472331200_B10","doi-asserted-by":"crossref","unstructured":"Kamel-Reid S, Letarte M, Sirard C, et al. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science\u20081989; 246: 1597\u2013600.","DOI":"10.1126\/science.2595371"},{"key":"2022061701472331200_B11","doi-asserted-by":"crossref","unstructured":"Uckun FM. Severe combined immunodeficient mouse models of human leukemia. Blood\u20081996; 88: 1135\u201346.","DOI":"10.1182\/blood.V88.4.1135.bloodjournal8841135"},{"key":"2022061701472331200_B12","doi-asserted-by":"crossref","unstructured":"Spiegel A, Kollet O, Peled A, et al. Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling. Blood\u20082004; 103: 2900\u20137.","DOI":"10.1182\/blood-2003-06-1891"},{"key":"2022061701472331200_B13","doi-asserted-by":"crossref","unstructured":"Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med\u20082000; 343: 1910\u20136.","DOI":"10.1056\/NEJM200012283432602"},{"key":"2022061701472331200_B14","doi-asserted-by":"crossref","unstructured":"Gryshchenko I, Hofbauer S, Stoecher M, et al. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia. J Clin Oncol\u20082008; 26: 2252\u20137.","DOI":"10.1200\/JCO.2007.11.5212"},{"key":"2022061701472331200_B15","doi-asserted-by":"crossref","unstructured":"Letestu R, Rawstron A, Ghia P, et al. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: a multicentric international harmonization process. Cytometry B Clin Cytom\u20082006; 70: 309\u201314.","DOI":"10.1002\/cyto.b.20132"},{"key":"2022061701472331200_B16","doi-asserted-by":"crossref","unstructured":"Peled A, Grabovsky V, Habler L, et al. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. J Clin Invest\u20081999; 104: 1199\u2013211.","DOI":"10.1172\/JCI7615"},{"key":"2022061701472331200_B17","doi-asserted-by":"crossref","unstructured":"Shamri R, Grabovsky V, Feigelson SW, Dwir O, Van Kooyk Y, Alon R. Chemokine stimulation of lymphocyte \u03b14 integrin avidity but not of leukocyte function-associated antigen-1 avidity to endothelial ligands under shear flow requires cholesterol membrane rafts. J Biol Chem\u20082002; 277: 40027\u201335.","DOI":"10.1074\/jbc.M206806200"},{"key":"2022061701472331200_B18","doi-asserted-by":"crossref","unstructured":"Grabovsky V, Feigelson S, Chen C, et al. Subsecond induction of \u03b14 integrin clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions. J Exp Med\u20082000; 192: 495\u2013506.","DOI":"10.1084\/jem.192.4.495"},{"key":"2022061701472331200_B19","doi-asserted-by":"crossref","unstructured":"Berlin-Rufenach C, Otto F, Mathies M, et al. Lymphocyte migration in lymphocyte function-associated antigen (LFA)-1-deficient mice. J Exp Med\u20081999; 189: 1467\u201378.","DOI":"10.1084\/jem.189.9.1467"},{"key":"2022061701472331200_B20","doi-asserted-by":"crossref","unstructured":"Grabovsky V, Dwir O, Alon R. Endothelial chemokines destabilize L-selectin-mediated lymphocyte rolling without inducing selectin shedding. J Biol Chem\u20082002; 277: 20640\u201350.","DOI":"10.1074\/jbc.M201763200"},{"key":"2022061701472331200_B21","doi-asserted-by":"crossref","unstructured":"Beals CR, Edwards AC, Gottschalk RJ, Kuijpers TW, Staunton DE. CD18 activation epitopes induced by leukocyte activation. J Immunol\u20082001; 167: 6113\u201322.","DOI":"10.4049\/jimmunol.167.11.6113"},{"key":"2022061701472331200_B22","doi-asserted-by":"crossref","unstructured":"Warnock RA, Askari S, Butcher EC, von Andrian UH. Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J Exp Med\u20081998; 187: 205\u201316.","DOI":"10.1084\/jem.187.2.205"},{"key":"2022061701472331200_B23","doi-asserted-by":"crossref","unstructured":"Berlin C, Bargatze RF, Campbell JJ, et al. \u03b14 Integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell\u20081995; 80: 413\u201322.","DOI":"10.1016\/0092-8674(95)90491-3"},{"key":"2022061701472331200_B24","doi-asserted-by":"crossref","unstructured":"Shanafelt TD, Geyer SM, Bone ND, et al. CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential. Br J Haematol\u20082008; 140: 537\u201346.","DOI":"10.1111\/j.1365-2141.2007.06965.x"},{"key":"2022061701472331200_B25","doi-asserted-by":"crossref","unstructured":"Yago T, Tsukuda M, Tajima H, et al. Analysis of initial attachment of B cells to endothelial cells under flow conditions. J Immunol\u20081997; 158: 707\u201314.","DOI":"10.4049\/jimmunol.158.2.707"},{"key":"2022061701472331200_B26","doi-asserted-by":"crossref","unstructured":"Cinamon G, Shinder V, Shamri R, Alon R. Chemoattractant signals and \u03b22 integrin occupancy at apical endothelial contacts combine with shear stress signals to promote transendothelial neutrophil migration. J Immunol\u20082004; 173: 7282\u201391.","DOI":"10.4049\/jimmunol.173.12.7282"},{"key":"2022061701472331200_B27","doi-asserted-by":"crossref","unstructured":"van Buul JD, Voermans C, van den Berg V, et al. Migration of human hematopoietic progenitor cells across bone marrow endothelium is regulated by vascular endothelial cadherin. J Immunol\u20082002; 168: 588\u201396.","DOI":"10.4049\/jimmunol.168.2.588"},{"key":"2022061701472331200_B28","doi-asserted-by":"crossref","unstructured":"Cyster JG. Lymphoid organ development and cell migration. Immunol Rev\u20082003; 195: 5\u201314.","DOI":"10.1034\/j.1600-065X.2003.00075.x"},{"key":"2022061701472331200_B29","doi-asserted-by":"crossref","unstructured":"Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol\u20082007; 7: 678\u201389.","DOI":"10.1038\/nri2156"},{"key":"2022061701472331200_B30","doi-asserted-by":"crossref","unstructured":"Schmidmaier R, Baumann P. Anti-adhesion evolves to a promising therapeutic concept in oncology. Curr Med Chem\u20082008; 15: 978\u201390.","DOI":"10.2174\/092986708784049667"},{"key":"2022061701472331200_B31","doi-asserted-by":"crossref","unstructured":"Gattei V, Bulian P, Del Principe MI, et al. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia. Blood\u20082008; 111: 865\u201373.","DOI":"10.1182\/blood-2007-05-092486"},{"key":"2022061701472331200_B32","doi-asserted-by":"crossref","unstructured":"Rossi D, Zucchetto A, Rossi FM, et al. CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia. Haematologica\u20082008; 93: 1575\u20139.","DOI":"10.3324\/haematol.13103"},{"key":"2022061701472331200_B33","doi-asserted-by":"crossref","unstructured":"Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood\u20081975; 46: 219\u201334.","DOI":"10.1182\/blood.V46.2.219.219"},{"key":"2022061701472331200_B34","doi-asserted-by":"crossref","unstructured":"Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer\u20081981; 48: 198\u2013206.","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V"},{"key":"2022061701472331200_B35","doi-asserted-by":"crossref","unstructured":"Saito S, Kuwashima N, Koizumi H, et al. In vivo function of homing receptors participating in lymphocyte recirculation: transfer analysis in SCID mice. Pathobiology\u20081995; 63: 305\u201313.","DOI":"10.1159\/000163966"},{"key":"2022061701472331200_B36","doi-asserted-by":"crossref","unstructured":"Durig J, Ebeling P, Grabellus F, et al. A novel nonobese diabetic\/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease. Cancer Res\u20082007; 67: 8653\u201361.","DOI":"10.1158\/0008-5472.CAN-07-1198"},{"key":"2022061701472331200_B37","doi-asserted-by":"crossref","unstructured":"Bichi R, Shinton SA, Martin ES, et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A\u20082002; 99: 6955\u201360.","DOI":"10.1073\/pnas.102181599"},{"key":"2022061701472331200_B38","doi-asserted-by":"crossref","unstructured":"Nadkarni JJ, Perambakam SM, Rathore VB, et al. Expression of adhesion molecules in B-cell chronic lymphocytic leukaemia: an analysis in lymphoid compartments\u2014peripheral blood, bone marrow and lymph node. Cancer Biother Radiopharm\u20081998; 13: 269\u201374.","DOI":"10.1089\/cbr.1998.13.269"},{"key":"2022061701472331200_B39","unstructured":"Lucio PJ, Faria MT, Pinto AM, et al. Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders. Haematologica\u20081998; 83: 104\u201311."},{"key":"2022061701472331200_B40","doi-asserted-by":"crossref","unstructured":"Bazerbashi MB, Reeve J, Chanarin I. Studies in chronic lymphocytic leukaemia. The kinetics of 51Cr-labelled lymphocytes. Scand J Haematol\u20081978; 20: 37\u201351.","DOI":"10.1111\/j.1600-0609.1978.tb01552.x"},{"key":"2022061701472331200_B41","doi-asserted-by":"crossref","unstructured":"Dormer P, Theml H, Lau B. Chronic lymphocytic leukemia: a proliferative or accumulative disorder? Leuk Res\u20081983; 7: 1\u201310.","DOI":"10.1016\/0145-2126(83)90052-8"},{"key":"2022061701472331200_B42","doi-asserted-by":"crossref","unstructured":"Till KJ, Lin K, Zuzel M, Cawley JC. The chemokine receptor CCR7 and \u03b14 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes. Blood\u20082002; 99: 2977\u201384.","DOI":"10.1182\/blood.V99.8.2977"},{"key":"2022061701472331200_B43","doi-asserted-by":"crossref","unstructured":"Patten PE, Buggins AG, Richards J, et al. CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood\u20082008; 111: 5173\u201381.","DOI":"10.1182\/blood-2007-08-108605"},{"key":"2022061701472331200_B44","unstructured":"Angelopoulou MK, Kontopidou FN, Pangalis GA. Adhesion molecules in B-chronic lymphoproliferative disorders. Semin Hematol\u20081999; 36: 178\u201397."},{"key":"2022061701472331200_B45","doi-asserted-by":"crossref","unstructured":"Till KJ, Spiller DG, Harris RJ, Chen H, Zuzel M, Cawley JC. CLL, but not normal, B cells are dependent on autocrine VEGF and \u03b14\u03b21 integrin for chemokine-induced motility on and through endothelium. Blood\u20082005; 105: 4813\u20139.","DOI":"10.1182\/blood-2004-10-4054"},{"key":"2022061701472331200_B46","doi-asserted-by":"crossref","unstructured":"Geijtenbeek TB, van Kooyk Y, van Vliet SJ, Renes MH, Raymakers RA, Figdor CG. High frequency of adhesion defects in B-lineage acute lymphoblastic leukemia. Blood\u20081999; 94: 754\u201364.","DOI":"10.1182\/blood.V94.2.754.414k11_754_764"},{"key":"2022061701472331200_B47","doi-asserted-by":"crossref","unstructured":"Zohren F, Toutzaris D, Klarner V, Hartung HP, Kieseier B, Haas R. The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans. Blood\u20082008; 111: 3893\u20135.","DOI":"10.1182\/blood-2007-10-120329"},{"key":"2022061701472331200_B48","doi-asserted-by":"crossref","unstructured":"Lichterfeld M, Martin S, Burkly L, Haas R, Kronenwett R. Mobilization of CD34+ haematopoietic stem cells is associated with a functional inactivation of the integrin very late antigen 4. Br J Haematol\u20082000; 110: 71\u201381.","DOI":"10.1046\/j.1365-2141.2000.02130.x"},{"key":"2022061701472331200_B49","doi-asserted-by":"crossref","unstructured":"Hamblin TJ, Orchard JA, Ibbotson RE, et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood\u20082002; 99: 1023\u20139.","DOI":"10.1182\/blood.V99.3.1023"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/7\/3121\/2622950\/3121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/7\/3121\/2622950\/3121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T09:50:49Z","timestamp":1684921849000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/7\/3121\/552984\/Circulating-B-Cell-Chronic-Lymphocytic-Leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,1]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2009,4,1]]},"published-print":{"date-parts":[[2009,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-4136","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22380209.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380212.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380206.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380224.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380221.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380221","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380212","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380227.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380203","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380224","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380227","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380218.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380203.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380218","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380206","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380209","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6499490.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499490","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,1]]}}}